1387 related articles for article (PubMed ID: 17982500)
21. [Regression of lid-parallel conjunctival folds (LIPCOF) on topical treatment with Liposic Eye Gel--a pilot study].
Höh H; Schwanengel M
Klin Monbl Augenheilkd; 2006 Nov; 223(11):918-23. PubMed ID: 17131254
[TBL] [Abstract][Full Text] [Related]
22. Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure.
Rummenie VT; Matsumoto Y; Dogru M; Wang Y; Hu Y; Ward SK; Igarashi A; Wakamatsu T; Ibrahim O; Goto E; Luyten G; Inoue H; Saito I; Shimazaki J; Tsubota K
Cytokine; 2008 Aug; 43(2):200-8. PubMed ID: 18602273
[TBL] [Abstract][Full Text] [Related]
23. [Dry eye in graft-versus-host disease].
Fei WL; Chen JQ; Du X; Liu YH; Sun MX; Lin JX; Weng JY; Luo TZ; Yin DM; Luo XY
Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):686-90. PubMed ID: 14766066
[TBL] [Abstract][Full Text] [Related]
24. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K
Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
[TBL] [Abstract][Full Text] [Related]
25. Ophthalmic cyclosporine use in ocular GVHD.
Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
[TBL] [Abstract][Full Text] [Related]
26. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Barber LD; Pflugfelder SC; Tauber J; Foulks GN
Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
[TBL] [Abstract][Full Text] [Related]
27. The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings.
Onguchi T; Dogru M; Okada N; Kato NA; Tanaka M; Takano Y; Fukagawa K; Shimazaki J; Tsubota K; Fujishima H
Am J Ophthalmol; 2006 Mar; 141(3):569-71. PubMed ID: 16490512
[TBL] [Abstract][Full Text] [Related]
28. Qualitative tear film and conjunctival goblet cell assessment of cats with corneal sequestra.
Grahn BH; Sisler S; Storey E
Vet Ophthalmol; 2005; 8(3):167-70. PubMed ID: 15910369
[TBL] [Abstract][Full Text] [Related]
29. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
[TBL] [Abstract][Full Text] [Related]
30. Sjögren-like syndrome after bone marrow transplantation.
Kosrirukvongs P; Chirapapaisan N; Visuthisakchai S; Issaragrisil S; Gonggetyai V
J Med Assoc Thai; 2008 Nov; 91(11):1739-47. PubMed ID: 19127798
[TBL] [Abstract][Full Text] [Related]
31. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings.
Wang Y; Dogru M; Matsumoto Y; Ward SK; Ayako I; Hu Y; Okada N; Ogawa Y; Shimazaki J; Tsubota K
Am J Ophthalmol; 2007 Dec; 144(6):930-937. PubMed ID: 17916317
[TBL] [Abstract][Full Text] [Related]
32. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
Su MY; Perry HD; Barsam A; Perry AR; Donnenfeld ED; Wittpenn JR; D'Aversa G
Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074
[TBL] [Abstract][Full Text] [Related]
33. The treatment of severe trachomatous dry eye with canalicular silicone plugs.
Guzey M; Ozardali I; Kilic A; Basar E; Dogan Z; Satici A; Karadede S
Eye (Lond); 2001 Jun; 15(Pt 3):297-303. PubMed ID: 11450724
[TBL] [Abstract][Full Text] [Related]
34. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
[TBL] [Abstract][Full Text] [Related]
35. A clinical evaluation of Systane.
Gifford P; Evans BJ; Morris J
Cont Lens Anterior Eye; 2006 Mar; 29(1):31-40. PubMed ID: 16473547
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye.
Guzey M; Karaman SK; Satici A; Ozardali I; Sezer S; Bozkurt O
Clin Exp Ophthalmol; 2009 Aug; 37(6):541-9. PubMed ID: 19702702
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease.
Yoon KC; Jeong IY; Im SK; Park YG; Kim HJ; Choi J
Bone Marrow Transplant; 2007 Feb; 39(4):231-5. PubMed ID: 17211430
[TBL] [Abstract][Full Text] [Related]
38. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
Roberts CW; Carniglia PE; Brazzo BG
Cornea; 2007 Aug; 26(7):805-9. PubMed ID: 17667613
[TBL] [Abstract][Full Text] [Related]
39. Tear function and ocular surface findings in premature and term babies.
Dogru M; Karakaya H; Baykara M; Ozmen A; Koksal N; Goto E; Matsumoto Y; Kojima T; Shimazaki J; Tsubota K
Ophthalmology; 2004 May; 111(5):901-5. PubMed ID: 15121366
[TBL] [Abstract][Full Text] [Related]
40. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
